Presenting an overview of challenges faced in early-phase studies and the corresponding technologies that help overcome and eliminate these issues.
"As 2022 comes to a close, it’s exciting to look back at how ACRP continues to adapt and meet or exceed the needs and expectations of clinical research professionals around the world."
With all the good technological strides we have taken as a field, it is important to also hear, acknowledge, and adequately address the concerns of clinical researchers and patients alike when moving forward.
Instead of seeing clinical data management as a technical, back-office process separate from clinical operations, progressive leaders recognize its crucial role in improving trial efficiency.
Development Velocity is a mission-critical metric that yields financial benefits and expedites time to market by enhancing both sides of pharma’s ledger through cost reductions and earlier revenue.